Status:

UNKNOWN

Non-invasive Left Ventricle Contractility dp/dt as Prognostic Marker in Chest Unit Patients

Lead Sponsor:

University of Monastir

Conditions:

Chest Pain

Eligibility:

All Genders

18+ years

Brief Summary

Ischemic heart disease is a major public health problem with high mortality rate despite the progress in management and the resources mobilized. The idea is that myocardial ischemia is generally assoc...

Detailed Description

Ischemic heart disease remains a major public health problem. Despite all the advances in the prognostic approach to ischemic heart disease, the risk of occurrence of major cardiovascular events is no...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • age over 18 years old,
  • acute chest pain
  • Exclusion criteria:
  • traumatic chest pain,
  • hemodynamic instability;
  • arrhythmias;
  • holders of a pacemaker;
  • STEMI

Exclusion

    Key Trial Info

    Start Date :

    June 1 2022

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    September 30 2023

    Estimated Enrollment :

    500 Patients enrolled

    Trial Details

    Trial ID

    NCT05416112

    Start Date

    June 1 2022

    End Date

    September 30 2023

    Last Update

    May 16 2023

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Emergency Departement

    Monastir, Tunisia, 5000

    Non-invasive Left Ventricle Contractility dp/dt as Prognostic Marker in Chest Unit Patients | DecenTrialz